Acetrizoate sodium
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596257

CAS#: 129-63-5

Description: Sodium acetrizoate (rINN, trade names Urokon, Triurol and Salpix), the sodium salt of acetrizoic acid, is a high-osmolality, water-soluble, iodine-based radiographic contrast medium.


Chemical Structure

img
Acetrizoate sodium
CAS# 129-63-5

Theoretical Analysis

MedKoo Cat#: 596257
Name: Acetrizoate sodium
CAS#: 129-63-5
Chemical Formula: C9H5I3NNaO3
Exact Mass:
Molecular Weight: 578.84
Elemental Analysis: C, 18.67; H, 0.87; I, 65.77; N, 2.42; Na, 3.97; O, 8.29

Price and Availability

Size Price Availability Quantity
50.0mg USD 310.0 2 Weeks
Bulk inquiry

Synonym: Acetrizoate sodium; MP 1023; MP-1023; MP1023; Reopak; Diaginol; Sodium acetrizoate;

IUPAC/Chemical Name: sodium 3-acetamido-2,4,6-triiodobenzoate

InChi Key: UCPVOMHRDXMAIZ-UHFFFAOYSA-M

InChi Code: InChI=1S/C9H6I3NO3.Na/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16;/h2H,1H3,(H,13,14)(H,15,16);/q;+1/p-1

SMILES Code: O=C([O-])C1=C(I)C=C(I)C(NC(C)=O)=C1I.[Na+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 578.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: The MICAD Research Team. N-(2,3-Dihydroxypropyl)-N´-(2-hydroxyethyl)-5-[N-(2,3-dihydroxypropyl)acetamido]- 2,4,6-triiodoisophthalamide. 2006 Jul 12 [updated 2006 Aug 9]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26369/ PubMed PMID: 20641973.

2: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2 ,4,6-triiodoisophthalamide. 2006 Mar 6 [updated 2008 Mar 4]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26367/ PubMed PMID: 20641971.

3: Cheng KT. N,N´-Bis(2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodois ophthalamide. 2006 Feb 7 [updated 2008 Feb 7]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK26366/ PubMed PMID: 20641970.

4: Cheng KT. 5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxyp ropyl)-2,4,6-triiodoisophthalamide. 2006 May 16 [updated 2008 Apr 21]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK25584/ PubMed PMID: 20641966.

5: Tjøtta E, Hungnes O, Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol. 1991 Dec;35(4):223-7. PubMed PMID: 1802953.

6: Nanaumi K. [Contrast media used in digestive tract radiography]. Rinsho Hoshasen. 1988 Oct;33(11):1181-3. Japanese. PubMed PMID: 3225911.

7: Strauss HJ, Scheel W, Runkewitz V. [Coated tracheobronchography using microcrystalline Visotrast acid--an animal experiment study]. Radiol Diagn (Berl). 1988;29(2):279-84. German. PubMed PMID: 3387558.

8: Rosling BG, Slots J, Christersson LA, Gröndahl HG, Genco RJ. Topical antimicrobial therapy and diagnosis of subgingival bacteria in the management of inflammatory periodontal disease. J Clin Periodontol. 1986 Nov;13(10):975-81. PubMed PMID: 3466909.

9: Zurth C. Mechanism of renal excretion of various X-ray contrast materials in rabbits. Invest Radiol. 1984 Mar-Apr;19(2):110-5. PubMed PMID: 6533099.

10: Böhlke R, Marzotko M. [Combined use of droperidol and xylocitin in peripheral arteriography]. Radiol Diagn (Berl). 1984;25(3):255-7. German. PubMed PMID: 6484132.

11: Ma YM, Mei F, Yu YG, Yuan XJ, Luo MC, Tong SG. [Autoradiographic localization of a new hepatographic agent TABAC in liver cells]. Zhongguo Yao Li Xue Bao. 1983 Mar;4(1):49-51. Chinese. PubMed PMID: 6223499.

12: Mei F, Zhuang XJ, Qian YX, Chen XR. Studies on an aromatic iodo-compound. Experimental and clinical studies of the contrast medium for hepatolienography. Chin Med J (Engl). 1983 Jan;96(1):13-20. PubMed PMID: 6403305.

13: Moore DE. Pain associated with hysterosalpingography: Ethiodol versus Salpix media. Fertil Steril. 1982 Nov;38(5):629-31. PubMed PMID: 6290276.

14: Ipinza I. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography]. Rev Med Chil. 1982 Aug;110(8):761-5. Spanish. PubMed PMID: 7156610.

15: Schütte HE. Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography. Diagn Imaging. 1982;51(6):277-83. PubMed PMID: 7173007.

16: Belykh AG. [Effect of contrast media on the structure and function of hepatocyte plasma membranes]. Farmakol Toksikol. 1981 May-Jun;44(3):322-6. Russian. PubMed PMID: 6456930.

17: Ma YM, Mei F, Luo MC, Xi NZ, Chen XR. [Pharmacokinetic studies on the intravenous suspension of a new hepatosplenography agent (author's transl)]. Yao Xue Xue Bao. 1981 Mar;16(3):218-24. Chinese. PubMed PMID: 7246172.

18: Wennberg A. Biological evaluation of root canal antiseptics using in vitro and in vivo methods. Scand J Dent Res. 1980 Feb;88(1):46-52. PubMed PMID: 6929085.

19: Rytter M, Hofmann C, Haustein UF. [Separation of lymphocytes by using visotrast 370 (author's transl)]. Allerg Immunol (Leipz). 1980;26(2):161-70. German. PubMed PMID: 6449843.

20: Peter JD. [Accidents caused by contrast media used in uro-angiography]. Anesth Analg (Paris). 1977 Sep-Oct;34(5):1029-37. French. PubMed PMID: 77647.